For the first time ever, a patient has received an allogeneic stem cell transplant using a deceased donor graft as part of a blood cancer clinical trial at Huntsman Cancer Institute at the University ...

Transplanted autologous corneal stem cells successfully repaired corneal injuries in patients. Over 90% of patients achieved complete or partial success. The procedure proved safe with no serious ...

Phase I clinical trial results suggest that an antibody treatment, used in combination with other drugs, enabled stem cell transplants for three children with Fanconi anemia without toxic busulfan ...

Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for leukemia significantly improves patient outcomes post-transplant, reducing ...

Dr. Sherif Farag, right, talks to the first patient of the Stem Cell Transplant and Cellular Therapy Institute through Community MD Anderson Cancer Center in Kokomo in 2024. The program, which Farag ...

Fred Hutch Cancer Center hematologists took center stage at the 2026 Tandem Meetings, a multidisciplinary meeting of experts in the field of blood stem cell transplantation, held in Salt Lake City ...

March 6 -- In the first operation of its kind, doctors used stem cells from a 16-year-old Almont, Mich., boy's own blood to repair his heart after he was accidentally shot in the heart with a nail gun ...

A diagnosis of acquired von Willebrand disease and stage 2 multiple myeloma followed unusual symptoms, leading to extensive testing. Treatment included a four-drug chemotherapy regimen and an ...

TWO young women from Jersey – one who gave a life-saving donation and another whose life was saved by a stranger – have joined forces to urge Islanders to take a simple step that could mean the ...

A bone marrow transplant, or stem cell transplant, places blood stem cells back into the body. The transplant replaces cells that cancer or treatments have destroyed. People may have a bone marrow ...

Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...